Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus

Journal of Infection

Volumn 66, Issue 5, 2013, Pages 447-452

  Yin, Yuzhu ^a   Wu, Lingling ^a   Zhang, Jun ^a   Zhou, Jin ^a   Zhang, Peizhen ^a   Hou, Hongying ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hepatitis B virus infection; Immunoprophylaxis failure; Risk factor analysis; Vertical transmission

Indexed keywords

HBVAC; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ARTICLE; BIRTH; BLOOD LEVEL; DELIVERY; DRUG TREATMENT FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPROPHYLAXIS; INFANT; INFANT FEEDING; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN CARE; PASSIVE IMMUNIZATION; PREGNANT WOMAN; PUERPERIUM; RISK FACTOR; TREATMENT DURATION; VERTICAL TRANSMISSION; VIRUS LOAD;

ADULT; BREAST FEEDING; CHI-SQUARE DISTRIBUTION; CHINA; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIGENS; HUMANS; IMMUNIZATION, PASSIVE; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LOGISTIC MODELS; MILK, HUMAN; POST-EXPOSURE PROPHYLAXIS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 84875600381     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.12.008     Document Type: Article

References (28)

1. Margolis H.S. Hepatitis B virus infection. Bull World Health Organ 1998, 76(Suppl. 2):152-153.
2. de Franchis R., Hadengue A., Lau G., Lavanchy D., Lok A., McIntyre N., et al. EASL International Consensus Conference on hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol 2003, 39(Suppl. 1):S3-25.
3. Zeng Z., Guan L., An P., Sun S., O'Brien S.J., Winkler C.A. A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population. BMC Infect Dis 2008, 8(1). 1471-2334-8-1 [pii]. 10.1186/1471-2334-8-1.
4. Song Y.M., Sung J., Yang S., Choe Y.H., Chang Y.S., Park W.S. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr 2007 Aug, 166(8):813-818. 10.1007/s00431-006-0327-5.
5. Tada H., Yanagida M., Mishina J., Fujii T., Baba K., Ishikawa S., et al. Combined passive and active immunization for preventing perinatal transmission of hepatitis B virus carrier state. Pediatrics 1982 Oct, 70(4):613-619.
6. Yu M., Jiang Q., Ji Y., Jiang H., Wu K., Ju L., et al. The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus. Eur J Clin Microbiol Infect Dis 2012 Feb 8, 10.1007/s10096-012-1557-2.
7. Li X.M., Shi M.F., Yang Y.B., Shi Z.J., Hou H.Y., Shen H.M., et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 2004 Nov 1, 10(21):3215-3217.
8. Ranger-Rogez S., Alain S., Denis F. Hepatitis viruses: mother to child transmission. Pathol Biol (Paris) 2002 Nov, 50(9):568-575. S0369811402003516 [pii].
9. Zou H.B., Chen Y., Zhang H., Duan Z.P., Li J., Zhuang H., et al. Prevention of hepatitis B virus vertical transmission: current situation and challenges. Zhonghua Gan Zang Bing Za Zhi 2010 Jul, 18(7):556-558.
10. Ngui S.L., Andrews N.J., Underhill G.S., Heptonstall J., Teo C.G. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998 Jul, 27(1):100-106.
11. Petrova M., Kamburov V. Breastfeeding and chronic HBV infection: clinical and social implications. World J Gastroenterol 2010 Oct 28, 16(40):5042-5046.
12. Yang J., Zeng X.M., Men Y.L., Zhao L.S. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus-a systematic review. Virol J 2008, 5:100. 1743-422X-5-100 [pii]. 10.1186/1743-422X-5-100.
13. Wang J., Zhu Q., Zhang X. Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis. Chin Med J (Engl) 2002 Oct, 115(10):1510-1512.
14. Zheng Y., Lu Y., Ye Q., Xia Y., Zhou Y., Yao Q., et al. Should chronic hepatitis B mothers breastfeed? a meta analysis. BMC Public Health 2011, 11:502. 1471-2458-11-502. 10.1186/1471-2458-11-502.
15. Wang J.S., Zhu Q.R., Wang X.H. Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier mothers. Int J Clin Pract 2003 Mar, 57(2):100-102.
16. Andre F.E., Zuckerman A.J. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol 1994 Oct, 44(2):144-151.
17. Fan Y., Xiao X.M. Meta-analysis on the effect of delivery mode on maternal -infant transmission of hepatitis B virus. Matern Child Health Care China 2007, 22:377-378.
18. Beasley R.P., Trepo C., Stevens C.E., Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977 Feb, 105(2):94-98.
19. Singh A.E., Plitt S.S., Osiowy C., Surynicz K., Kouadjo E., Preiksaitis J., et al. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat 2011, 18(7):468-473.
20. Zou H., Chen Y., Duan Z., Zhang H., Pan C. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat 2012 Feb, 19(2):e18-e25. 10.1111/j.1365-2893.2011.01492.x.
21. del Canho R., Grosheide P.M., Mazel J.A., Heijtink R.A., Hop W.C., Gerards L.J., et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 1997 Oct, 15(15):1624-1630. S0264-410X(97)00080-7 [pii].
22. Men K., Wang X., Xu Y.Y., Xu D.Z. Meta-analysis of role of hepatitis B e antigen and anti-HBe antibody in HBV mother-to-infant transmission. J Forth Milltary Med Univ 2000, 21:692-694.
23. Lin H.H., Chang M.H., Chen D.S., Sung J.L., Hong K.H., Young Y.C., et al. Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure. Vaccine 1991 Jun, 9(6):457-460.
24. Smith C.P., Parle M., Morris D.J. Implementation of government recommendations for immunising infants at risk of hepatitis B. BMJ 1994 Nov 19, 309(6965):1339.
25. Mast E.E., Mahoney F.J., Alter M.J., Margolis H.S. Progress toward elimination of hepatitis B virus transmission in the United States. Vaccine 1998 Nov, 16(Suppl):S48-S51.
26. Cui H.C., Yan Y.H., Shao Z.J., Xu D.Z., Men K., Xu J.Q., et al. Effect of HBIG on blocking mother-to-infant transmission of HBV. J Forth Milltary Med Univ 2006, 27:1027-1030.
27. Shi Z., Li X., Ma L., Yang Y. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis 2010 Jul, 14(7):e622-e634. S1201-9712(10)00003-2 [pii]. 10.1016/j.ijid.2009.09.008.
28. Singh A.E., Plitt S.S., Osiowy C., Surynicz K., Kouadjo E., Preiksaitis J., et al. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat 2011 Jul, 18(7):468-473. JVH1333 [pii]. 10.1111/j.1365-2893.2010.01333.x.